The Impact of Levosimendan on Survival and Weaning from ECMO after Extracorporeal Cardiopulmonary Resuscitation.
Christopher GaisendreesGeorg SchlachtenbergerStephen GeferIhor KrasivskyiIlija DjordjevicAnton SabashnikovMarinos KosmopoulosDeborah JaegerMaximilian LuehrElmar KuhnAntje-Christin DeppeThorsten WahlersPublished in: Artificial organs (2023)
In patients after cardiac arrest treated with eCPR, Levosimendan seems to contribute to higher success rates of ECMO weaning, potentially due to a short to mid-term increase in inotropy. Also, the survival after Levosimendan application was higher than patients who did not receive levosimendan.
Keyphrases
- cardiopulmonary resuscitation
- cardiac arrest
- cardiac surgery
- extracorporeal membrane oxygenation
- mechanical ventilation
- acute respiratory distress syndrome
- end stage renal disease
- newly diagnosed
- acute kidney injury
- peritoneal dialysis
- prognostic factors
- intensive care unit
- patient reported outcomes
- free survival